Evidence map›Paper›PMID 20382327›Full record

ReviewLancet (London, England)2010

Kidney regeneration.

Ariela Benigni, Marina Morigi, Giuseppe Remuzzi

Registry-linked trialOpen access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Lancet (London, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03939741 (Evaluation of Therapeutic Potential of Stromal Vascular Fraction), which is not on this map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03939741 phase1 / phase2unknown statusnot on this mapstarted 2019, after this paper: background citation

Evaluation of Therapeutic Potential of Stromal Vascular Fraction (Autologous Adipose Derived Mesenchymal Stem Cell) Based Treatment for Chronic Kidney Disease

TypeinterventionalSponsorBangladesh Laser & Cell Surgery Institute & HospitalRan2019 to 2025Enrolled31ConditionsChronic Kidney DiseasesArmsSVF Containg Autologous Non Expanded ADSC
3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 130 citations in OpenAlex.

  1. Trial
  2. A human in vitro model that mimics the renal proximal tubule.Tissue engineering. Part C, Methods · 2014
    Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Use of mesenchymal stem cells for chronic kidney disease.Kidney research and clinical practice · 2019
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ariela BenigniMario Negri Institute for Pharmacological Research, Bergamo, Italy. ariela.benigni@marionegri.it
Marina Morigi
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neonephrogenesis, the capacity to regenerate renal tissue, is a distinctive feature of fish but not usually of mammals. However, evidence exists for kidney repair in response to insulting agents for animals and human beings. Studies have therefore been designed in the past few years to clarify the cellular and molecular basis of renal repair, with the aim to investigate the potential regenerative capacity of animal and human kidneys. Three main questions are being addressed by this research: whether terminally differentiated cells in adult animal kidneys have regenerative capacity; whether multipotent progenitor cells exist in kidneys; and whether renal repair can be favoured or accelerated by cells of extrarenal origin migrating to the kidney in response to injury. In this Review, we describe evidence of cellular and molecular pathways related to renal repair and regeneration, and review data from animal and human studies that show that the kidney might have regenerative capacity.

Indexed as

RegenerationAnimalsBone Marrow CellsHumansKidneyKidney DiseasesMultipotent Stem CellsStem Cells

Identifiers

PMID20382327
OpenAlexW4231762600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.